Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay.
Kieninger, MP; Caballero, EG; Sosa, AA; Amarilla, CT; Jáuregui, B; Janusz, CB; CLARK, AD; Castellanos, RM;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.078.
Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.
Lule, SA; MAWA, PA; NKURUNUNGI, G; Nampijja, M; Kizito, D; Akello, F; Muhangi, L; ELLIOTT, AM; WEBB, EL;
2014
Vaccine, (2014).33 6 10.1016/j.vaccine.2014.12.015.
Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei, C; Odaga, J; Mvundura, M; Madrid, Y; CLARK, AD; Kenya ProVac Technical Working Group,; Uganda ProVac Technical Working Group,;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.079.
Cost-effectiveness of rotavirus vaccination in Albania.
Ahmeti, A; Preza, I; Simaku, A; Nelaj, E; CLARK, AD; Felix Garcia, AG; Lara, C; Hoestlandt, C; Blau, J; Bino, S;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.075.
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru.
Mezones-Holguin, E; Canelo-Aybar, C; CLARK, AD; Janusz, CB; Jaúregui, B; Escobedo-Palza, S; Hernandez, AV; Vega-Porras, D; González, M; Fiestas, F; Toledo, W; Michel, F; Suárez, VJ;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.039.
Cost-effectiveness of HPV vaccination in Belize.
Walwyn, L; Janusz, CB; CLARK, AD; Prieto, E; Waight, E; Largaespada, N;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.042.
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes, HM D; De Soárez, PC; Silva, GA; Ayres, A; Itria, A; Rama, CH; Sartori, AM C; CLARK, AD; Resch, S;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.031.
Cost-effectiveness of pneumococcal conjugate vaccination in Georgia.
Komakhidze, T; Hoestlandt, C; Dolakidze, T; Shakhnazarova, M; Chlikadze, R; Kopaleishvili, N; Goginashvili, K; Kherkheulidze, M; CLARK, AD; Blau, J;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.070.
Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina, VV; Filipović, SK; Kožnjak, N; Stamenić, V; CLARK, AD; Mounaud, B; Blau, J; Hoestlandt, C; Kaić, B;
2014
Vaccine, (2014).33 Sup S1 10.1016/j.vaccine.2014.12.043.
Impaired natural killer cell responses to vaccine antigens in human cytomegalovirus-infected individuals.
Nielsen, CM; White, MJ; Rodriguez-Galan, A; BOTTOMLEY, C; Turner, SE G; GOODIER, MR; Riley, EM;
2014
IMMUNOLOGY, (2014).143,